NCT02668367View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
PharmacokineticsHealthy Volunteers
Interventions
DRUG

BTA-C585 oral capsules

BTA-C585; Multiple ascending doses from 100 mg to 600 mg

DRUG

BTA-C585 matching placebo

Multiple ascending doses to match 100 mg to 600 mg BTA-C585 capsules

Trial Locations (1)

78209

Biota Investigational Site, San Antonio

Sponsors
All Listed Sponsors
lead

Biota Pharmaceuticals, Inc.

INDUSTRY

NCT02668367 - Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers | Biotech Hunter | Biotech Hunter